PL BioScience
The platform of tailored cell culture supplements based on human Platelets.
Launch date
Employees
Market cap
-
Enterprise valuation
€31—47m (Dealroom.co estimates Aug 2024.)
Company register number HRB 19554
Aachen Nordrhein-Westfalen (HQ)
Financials
Estimates*
| EUR | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Profit | (<1m) | (<1m) | (<1m) | (1.2m) |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Early VC | ||
€3.7m | Seed | ||
* | €7.8m | Series A | |
| Total Funding | €11.5m | ||
Related Content
Recent News about PL BioScience
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.